Distinguishing benign lesions from malignant ones using FAPI-based tracers: will we need to bid farewell to dual-time points imaging?

Priscilla Guglielmo^{1

2}, Laura Evangelista^{3

4}

Affiliations

¹ Nuclear Medicine Unit, Humanitas Gavazzeni, Bergamo, Italy. priscilla.guglielmo@yahoo.it.
² Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy. priscilla.guglielmo@yahoo.it.
³ Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
⁴ Nuclear Medicine Unit, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.

Priscilla Guglielmo et al. Eur J Nucl Med Mol Imaging. 2025.

. 2025 Apr 9.

doi: 10.1007/s00259-025-07254-7. Online ahead of print.

Priscilla Guglielmo^{1

2}, Laura Evangelista^{3

4}

¹ Nuclear Medicine Unit, Humanitas Gavazzeni, Bergamo, Italy. priscilla.guglielmo@yahoo.it.
² Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy. priscilla.guglielmo@yahoo.it.
³ Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
⁴ Nuclear Medicine Unit, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.

No abstract available

Conflict of interest statement

Declarations. Competing interests: The authors have no relevant financial or non-financial interests to disclose.

1. Chen R, Yang X, Li L, Zhao H, Huang G, Liu J. Distinguishing benign from malignant lesions with high [68 Ga]Ga-FAPI-04 uptake in oncology patients: insights from dynamic Total-Body [68 Ga]Ga-FAPI-04 PET/CT. Eur J Nucl Med Mol Imaging. 2024. https://doi.org/10.1007/s00259-024-07029-6 . - DOI - PubMed - PMC
1. Houshmand S, Salavati A, Basu S, Khiewvan B, Alavi A. The role of dual and multiple time point imaging of FDG uptake in both normal and disease States. Clin Transl Imaging. 2014;2:281–93. https://doi.org/10.1007/s40336-014-0075-x . - DOI
1. Kaneko K, Nagao M, Yamamoto A, Yano K, Honda G, Tokushige K, Sakai S. Patlak reconstruction using dynamic 18F-FDG PET imaging for evaluation of malignant liver tumors. Clin Nucl Med. 2024;49:116–23. https://doi.org/10.1097/RLU.0000000000005013 . - DOI - PubMed
1. Boanova LG, Altmayer S, Watte G, Raupp AA, Francisco MZ, De Oliveira GS, Hochhegger B, Andrade RGF. Detection of liver lesions in colorectal cancer patients using 18F-FDG PET/CT Dual-Time-Point scan imaging. Cancers (Basel). 2023;15:5403. https://doi.org/10.3390/cancers15225403 . - DOI - PubMed
1. Yen Y-A, Huang W-S, Chiu C-H, Tyan Y-C, Wang J-J, Wu L-C, Feng IJ, Lee CH. Does routine Triple-Time-Point FDG PET/CT imaging improve the detection of liver metastases?? Diagnostics. 2020;10:609. https://doi.org/10.3390/diagnostics10090609 . - DOI - PubMed - PMC